Similarly, the expression of IL-7 and CCL19 in CAR-GPC3 T cells can promote T cell survival and tumor infiltration, leading to stronger tumor suppression compared to traditional CAR-T cells in xenograft and PDX models [169]. The gene discussed is CCL19; the disease is neoplasm.